By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Pharmaceuticals

In the last 24 hours

ASH23: CAR-T for autoimmune disease, real-world questions and sickle cell’s social media… BioPharma Dive20:33 9-Dec-23

BeiGene builds out long-term case for Brukinsa in CLL, despite an overall survival miss: #ASH23 ENDPOINTS17:52 9-Dec-23

Nigerians in dire situation as pharmaceutical sector grapples with crisis over spiraling drug… Politics Nigeria01:26

Arcellx, Kite aim to keep chipping away at Carvykti advantage with new multiple myeloma data at ASH ENDPOINTS20:24 9-Dec-23

ASH: Pfizer, swimming in crowded waters, eyes wide impact for sickle cell, hemophilia assets FierceBiotech19:04 9-Dec-23

STAT Plus: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first… STAT12:36 9-Dec-23

view more headlines

In the last 48 hours

Eli Lilly granted planning for Dunderrow expansion Echo Live06:10 9-Dec-23

Colorado blames Biden team and drugmakers for delaying Canadian imports The Colorado Sun04:23 9-Dec-23

Vertex/CRISPR Nab First-Ever Gene Editing FDA Nod, Overshadow Bluebird’s Same-Day Win Scrip Pharma Intelligence00:50 9-Dec-23

Some Covid Vaccines Produce ‘Unintended Immune Response’ in Recipients: Study The Epoch Times17:18 8-Dec-23

Novo Nordisk Must Face Bulk Of Woman's Ozempic Injury Suit Law36017:03 8-Dec-23

Maker of $32,000 lead poisoning antidote pledges to create assistance program to help uninsured … CNN16:01 8-Dec-23

Merck (MRK) Shares Cross 3% Yield Mark Nasdaq15:54 8-Dec-23

Bluebird Bio Shares Slide 41% on Black-Box Label, Higher Price for Sickle-Cell Treatment MarketWatch15:44 8-Dec-23

In brief: Novartis welcomes "significant milestone" for Kisqali London South East15:10 8-Dec-23

U.S. approves two ‘breakthrough’ gene therapies for sickle cell treatment Peoples Gazette14:27 8-Dec-23

What to know about CRISPR gene-editing technology Boston Globe12:35 8-Dec-23

Man, 65, in Los Angeles develops a 'cheesy' yellow tumor on his shoulder after bizarre reaction … Mail Online12:24 8-Dec-23

U.S. FDA approves two gene therapies for sickle cell disease CTV News Edmonton12:11 8-Dec-23

view more headlines

In the last 4 days

CG Oncology’s bladder cancer drug gets fast track to approval Pharmaceutical Technology11:33 6-Dec-23

Pfizer plans to pull out of BIO, following moves by other large drugmakers to reduce lobbying footprint ENDPOINTS13:08 6-Dec-23

AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer PMLiVE07:28 8-Dec-23

Massachusetts Biotech Plummets as Skin Cancer Trial Fails Investorideas.com14:29 6-Dec-23

Antibody-immunotherapy combination shows promise in lung cancer European Pharmaceutical Review12:08 6-Dec-23

Bristol Myers’ lead deal negotiator to depart after inking series of multibillion-dollar acquisitions ENDPOINTS10:31 8-Dec-23

FDA accepts Alpha Cognition’s NDA for Alzheimer’s disease Pharmaceutical Technology05:50 8-Dec-23

Regeneron reports response rates for multiple myeloma bispecific linvoseltamab, setting up FDA filing and showdown with … ENDPOINTS07:05 7-Dec-23

Three phase IIIs: BMS, Merck and Sanofi release new cancer data BioWorld17:18 7-Dec-23

EC takes heat over new Pfizer vaccine contract after ‘secret texts’ scandal Brussels Signal10:35 8-Dec-23

CRISPR is about to make history. Here’s the 5-minute rundown of what to expect STAT09:40 8-Dec-23

FDA Could Approve First Crispr Treatment Today That Might Cure Sickle Cell Forbes07:31 8-Dec-23

FDA Clears First At-Home Kit for Artificial Insemination Medpage Today02:02 8-Dec-23

Merck halts trial after Keytruda-Lynparza combo flunks PhIII study in lung cancer ENDPOINTS14:21 7-Dec-23

White House says it will grab patents if companies set exorbitant prices for taxpayer-funded… The Washington Times11:03 7-Dec-23

AbbVie to expand neuroscience pipeline with $8.7bn Cerevel Therapeutics acquisition PMLiVE07:23 7-Dec-23

Sanofi, facing skeptical investors, predicts $5B sales for 3 drugs, names 9 more blockbusters FierceBiotech06:53 7-Dec-23

Artificial Hips Snapped in Half; Obesity Drug Windfall for Docs; Clinicians Unionize Medpage Today01:27 7-Dec-23

AbbVie enters agreement to acquire Cerevel Therapeutics Investing.com17:33 6-Dec-23

Merck KGaA’s experimental MS drug fails in late stage trials Proactive Investors (US)11:49 6-Dec-23

CRISPR therapy for sickle cell approved by FDA in gene editing milestone BioPharma Dive11:28 8-Dec-23

BioNTech lays out plan to build clinical-stage manufacturing site in Australia FiercePharma11:28 8-Dec-23

Vanda Buys US, Canadian Rights to J&J’s MS Drug Ponvory in $100M Deal BioSpace11:13 8-Dec-23

Nephron faces lawsuit over pain med competitor says it sold without FDA approval The State, South Carolina10:40 8-Dec-23

Novo, Lilly rivals explore booming weight-loss drug market entry Reuters10:11 8-Dec-23

view more headlines

In the last 7 days

Lilly’s Verzenio just misses the mark on overall survival in PhIII breast cancer study ENDPOINTS08:19 5-Dec-23

Roche to Buy Carmot Therapeutics for $2.7 Billion The Wall Street Journal02:55 4-Dec-23

Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for… BioSpace09:43 6-Dec-23

Death of J&J Executive’s Teenage Son Prompts Big Policy Change Bloomberg Law09:39 4-Dec-23

Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology BioSpace04:00 4-Dec-23

FDA sends letter to Novartis over 'significant' Kymriah manufacturing safety concerns ENDPOINTS15:26 5-Dec-23

AstraZeneca to build CGT center in Hong Kong BioProcess Insider10:39 4-Dec-23

Daiichi Sankyo unit claims $182m in Novartis patent dispute pharmaphorum06:44 6-Dec-23

Novartis’ Fabhalta is first FDA-cleared oral therapy for PNH pharmaphorum06:04 6-Dec-23

Merck Faces Major Setback as MS Drug Fails TipRanks03:47 6-Dec-23

Roche buys Telavant and its IBD drug for $7.1 billion Chemical & Engineering News03:20 6-Dec-23

IGM Biosciences to Reduce Workforce by 22% Amid Broader Restructuring MarketWatch16:36 5-Dec-23

FDA Soon Rules If First CRISPR Therapy Receives Commercial Approval Forbes09:41 5-Dec-23

J&J Sees 2024 Sales Growth Slowing as Top Drug Faces Competition BNN Bloomberg07:41 5-Dec-23

Another Flagship-founded biotech shutters as Axcella liquidates, ending long Covid plans ENDPOINTS03:23 5-Dec-23

Merck grabs late-stage oncology drug from China’s Abbisko pharmaphorum11:32 4-Dec-23

2023 Year in Review: Business Developments Genetic Engineering and Biotechnology News11:01 4-Dec-23

FDA Warns of Rare but Serious Drug Reaction to Antiseizure Medicines PharmTech.com10:21 4-Dec-23

Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01 BioSpace09:53 6-Dec-23

Outlook Therapeutics® Announces Strategic Organizational Realignment BioSpace09:23 6-Dec-23

Novartis secures first-of-a-kind haematology approval European Pharmaceutical Review09:05 6-Dec-23

Novartis' Rare Blood Disorder Therapy Scores FDA Approval Benzinga08:45 6-Dec-23

Novartis’ Fabhalta approved by FDA as first oral monotherapy for rare blood disease PNH PMLiVE07:49 6-Dec-23

Biocair eyes Irish expansion with Aramex Ireland partnership Business Plus Online07:46 6-Dec-23

Will the UK’s triple-pronged approach ease pricing, regulatory and financial bottlenecks? ENDPOINTS05:40 6-Dec-23

view more headlines

In the last 14 days

Turkish competition watchdog launches probe into 19 pharma companies Daily Sabah06:41 1-Dec-23

AstraZeneca calls off two phase III trials into hyperkalaemia treatment London South East04:03 1-Dec-23

Coherus prices China-made PD-1 drug Loqtorzi at 20% discount to Merck's Keytruda FiercePharma18:23 27-Nov-23

J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey FiercePharma11:13 1-Dec-23

AstraZeneca halts two PhIII hyperkalemia studies intended to spotlight Lokelma’s clinical value ENDPOINTS06:38 1-Dec-23

AZ drops two trials aimed at expanding Lokelma’s label pharmaphorum05:32 1-Dec-23

FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors BioSpace21:24 27-Nov-23

AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT Reuters01:36 3-Dec-23

Explore spectacular new interactive mosaic artwork at AstraZeneca’s Discovery Centre in Cambridge – made of 1,000 images Cambridge Independent08:14 2-Dec-23

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops CNBC08:02 2-Dec-23

Novartis taps ‘Sopranos’ actress for new multiple sclerosis Kesimpta campaign ENDPOINTS12:54 1-Dec-23

Maker of Wegovy, Ozempic showers money on U.S. obesity doctors Reuters07:02 1-Dec-23

SpringWorks Therapeutics Shares Skyrocket on FDA Approval of Desmoid Tumor Drug Investopedia12:31 29-Nov-23

Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock? The Motley Fool05:54 29-Nov-23

FDA to make decision about Karuna's schizophrenia drug by next September ENDPOINTS06:39 29-Nov-23

Teva Closes Collaboration Deal With Sanofi on IBD Treatment MarketWatch08:58 30-Nov-23

FDA launches wide probe into CAR-T therapy safety pharmaphorum13:48 28-Nov-23

Sanofi: A Shift In The Story Seeking Alpha01:28 28-Nov-23

GSK, AstraZeneca, Johnson & Johnson and others raided in Turkish labour market probe Global Competition Review11:31 1-Dec-23

Fast-tracked cancer drug candidate causes substantial levels of mutations and must be… ecancer08:12 1-Dec-23

Compounded Wegovy Matters Sink Novo Nordisk (NYSE:NVO) TipRanks11:47 30-Nov-23

AbbVie Buys ImmunoGen in $10B Deal, Gains Access to ADC for Ovarian Cancer BioSpace10:58 30-Nov-23

Acquisition deal to back European biosimilars market European Pharmaceutical Review09:10 30-Nov-23

BioNTech Rwanda vaccine manufacturing plant to be launched next month The New Times07:56 30-Nov-23

Vivos gets FDA clearance for Vivos’ CARE appliances to treat obstructive sleep apnoea NS Medical Devices23:41 29-Nov-23

view more headlines

About our Pharmaceuticals news

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.